Usefulness of Mavacamten in the Challenging Association of Aortic Stenosis and Obstructive Hypertrophic Cardiomyopathy
The association of aortic stenosis (AS) and obstructive hypertrophic cardiomyopathy raises questions about AS quantification, the management of left ventricular outflow tract obstruction, and AS treatment. Recently, mavacamten demonstrated its efficacy in reducing left ventricular outflow tract obstruction gradient. This case reports on mavacamten use in this challenging association.
Authors
- Yohann Bohbot (ORCID: https://orcid.org/0000-0002-2695-9848)
- Emilion Hucleux
- Pierre Vanhaecke (ORCID: https://orcid.org/0009-0009-2806-8203)
- Mokrane Yemmi
- Chloé Di Lena
- Chistophe Tribouilloy
Institutions
- Centre Hospitalier Universitaire Amiens-Picardie (FR)
- Laboratoire Jean-Alexandre Dieudonné (FR)
- Université de Picardie Jules Verne (FR)
Publication Details
- Journal
- JACC Case Reports
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1016/j.jaccas.2024.102430
- Citations
- 6
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.41